New European guidelines on atrial fibrillation

BMJ

Volumn 342, Issue 7805, 2011, Pages

  Hunter, Ross J ^a   Schilling, Richard J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DABIGATRAN; DRONEDARONE; FLECAINIDE; PROPAFENONE; SOTALOL; WARFARIN;

BLEEDING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CATHETER ABLATION; DISEASE CLASSIFICATION; EDITORIAL; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HIGH RISK PATIENT; HUMAN; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SINUS RHYTHM; STROKE; SYMPTOMATOLOGY;

ATRIAL FIBRILLATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; STROKE;

EID: 79953063977     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d897     Document Type: Editorial

References (12)

1. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
2. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72.
3. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
4. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
5. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42.
6. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004;109:1509-13. (Pubitemid 38420179)
7. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009;2:349-61.
8. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010;362:1363-73.
9. Hunter RJ, Berriman T, Diab I, Finlay M, Richmond L, Duncan E, et al. Long term efficacy of catheter ablation for AF: impact of additional targeting of fractionated electrograms. Heart 2010;96:1372-8.
10. Bhargava M, Di BL, Mohanty P, Prasad S, Martin DO, Williams-Andrews M, et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm 2009;6:1403-12.
11. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005;293:2634-40. (Pubitemid 40744248)
12. Khan MN, Jais P, Cummings J, Di BL, Sanders P, Martin DO, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008;359:1778-85.